Phase II study of Chemotherapy for Advanced or Recurrent Thymoma
Phase 2
- Conditions
- Thymoma (excluding thymic carcinoma)
- Registration Number
- JPRN-C000000350
- Lead Sponsor
- Japanese Association for Research on the Thymus
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with malignancies other than thymoma (those with CR can be included). Patients who has been treated with steroid pulse therapy within one month of the registration. Patients on oral steroid at a dose of more than 26mg every other day or 13mg everyday. Pregnant women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method Overall response Adverse effects